[go: up one dir, main page]

DE10075034I1 - Insulinderivate - Google Patents

Insulinderivate

Info

Publication number
DE10075034I1
DE10075034I1 DE2000175034 DE10075034C DE10075034I1 DE 10075034 I1 DE10075034 I1 DE 10075034I1 DE 2000175034 DE2000175034 DE 2000175034 DE 10075034 C DE10075034 C DE 10075034C DE 10075034 I1 DE10075034 I1 DE 10075034I1
Authority
DE
Germany
Prior art keywords
insulin derivatives
insulin
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE2000175034
Other languages
English (en)
Inventor
Liselotte Langkjaer
Kjeld Norris
Jan Markussen
Klavs Holger Jorgensen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27221014&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE10075034(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DK94887A external-priority patent/DK94887D0/da
Priority claimed from DK356987A external-priority patent/DK356987D0/da
Priority claimed from DK540087A external-priority patent/DK157901C/da
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Application granted granted Critical
Publication of DE10075034I1 publication Critical patent/DE10075034I1/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Emergency Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE2000175034 1987-02-25 1988-02-24 Insulinderivate Pending DE10075034I1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK94887A DK94887D0 (da) 1987-02-25 1987-02-25 Praeparat med fordelagtige egenskaber
DK356987A DK356987D0 (de) 1987-07-10 1987-07-10
DK540087A DK157901C (da) 1986-10-20 1987-10-16 Insulinpraeparat til parenteral administration indeholdende magnesiumioner

Publications (1)

Publication Number Publication Date
DE10075034I1 true DE10075034I1 (de) 2001-05-23

Family

ID=27221014

Family Applications (2)

Application Number Title Priority Date Filing Date
DE8888301590T Expired - Lifetime DE3880346T2 (de) 1987-02-25 1988-02-24 Insulinderivate.
DE2000175034 Pending DE10075034I1 (de) 1987-02-25 1988-02-24 Insulinderivate

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE8888301590T Expired - Lifetime DE3880346T2 (de) 1987-02-25 1988-02-24 Insulinderivate.

Country Status (12)

Country Link
EP (1) EP0280534B1 (de)
JP (1) JP2606915B2 (de)
AU (1) AU612141B2 (de)
CA (1) CA1339416C (de)
DE (2) DE3880346T2 (de)
ES (1) ES2053723T3 (de)
FI (1) FI884914L (de)
IE (1) IE62879B1 (de)
NL (1) NL300029I1 (de)
NZ (1) NZ223630A (de)
PT (1) PT86819B (de)
WO (1) WO1988006599A1 (de)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK257988D0 (da) * 1988-05-11 1988-05-11 Novo Industri As Nye peptider
DE3837825A1 (de) * 1988-11-08 1990-05-10 Hoechst Ag Neue insulinderivate, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung
US5716927A (en) * 1988-12-23 1998-02-10 Novo Nordisk A/S Insulin analogs having a modified B-chain
HUT56857A (en) * 1988-12-23 1991-10-28 Novo Nordisk As Human insulin analogues
US5514646A (en) * 1989-02-09 1996-05-07 Chance; Ronald E. Insulin analogs modified at position 29 of the B chain
CA2071382A1 (en) * 1991-06-21 1992-12-22 David N. Brems Insulin analogs
US6869930B1 (en) 1993-09-17 2005-03-22 Novo Nordisk A/S Acylated insulin
AU1272295A (en) * 1993-12-17 1995-07-03 Novo Nordisk A/S Proinsulin-like compounds
US5461031A (en) * 1994-06-16 1995-10-24 Eli Lilly And Company Monomeric insulin analog formulations
AUPP609198A0 (en) * 1998-09-22 1998-10-15 Curtin University Of Technology Use of non-peptidyl compounds for the treatment of insulin related ailments
US6933272B1 (en) 1998-09-22 2005-08-23 Erik Helmerhorst Use of non-peptidyl compounds for the treatment of insulin related ailments
DE10114178A1 (de) 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
RU2376379C2 (ru) 2001-11-19 2009-12-20 Ново Нордиск А/С Способ получения инсулиновых соединений
GB0206792D0 (en) 2002-03-22 2002-05-01 Leuven K U Res & Dev Normoglycemia
DE10227232A1 (de) 2002-06-18 2004-01-15 Aventis Pharma Deutschland Gmbh Saure Insulinzubereitungen mit verbesserter Stabilität
EP2301749A1 (de) 2003-06-27 2011-03-30 Novo Nordisk A/S Behälter für medizinische Flüssigkeiten mit hoher Wasserdampfsperre
JP2007515235A (ja) 2003-12-22 2007-06-14 ノボ・ノルデイスク・エー／エス 医薬液を保存するための、透明で、可撓性且つ不浸透性のプラスチック製容器
JP4874811B2 (ja) 2004-01-21 2012-02-15 ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト ペプチドのトランスグルタミナーゼ媒介性の結合
ES2391776T3 (es) 2004-11-22 2012-11-29 Novo Nordisk A/S Formulaciones solubles, estables conteniendo insulina con una sal de protamina
WO2008049711A1 (en) 2006-10-27 2008-05-02 Novo Nordisk A/S Peptide extended insulins
US20100120660A1 (en) * 2007-04-30 2010-05-13 Per Balschmidt Highly concentrated insulin solutions and compositions
NZ586589A (en) 2008-01-09 2012-04-27 Sanofi Aventis Deutschland Novel insulin analogues having an extremely delayed time-action profile
CN102007143B (zh) 2008-01-09 2015-08-26 塞诺菲-安万特德国有限公司 具有超延迟时效特征的新型胰岛素衍生物
TWI451876B (zh) 2008-06-13 2014-09-11 Lilly Co Eli 聚乙二醇化之離脯胰島素化合物
CN102159588B (zh) 2008-08-07 2015-09-02 拜康有限公司 一种用于制备胰岛素化合物的方法
US9526764B2 (en) 2008-10-17 2016-12-27 Sanofi-Aventis Deutschland Gmbh Combination of an insulin and a GLP-1-agonist
FR2943538B1 (fr) 2009-03-27 2011-05-20 Adocia Formulation a action rapide d'insuline recombinante humaine
US9018190B2 (en) 2009-03-27 2015-04-28 Adocia Functionalized oligosaccharides
WO2011058082A1 (de) 2009-11-13 2011-05-19 Sanofi-Aventis Deutschland Gmbh Pharmazeutische zusammensetzung umfassend einen glp-1-agonisten und methionin
HUE038147T2 (hu) 2009-11-13 2018-09-28 Sanofi Aventis Deutschland GLP-1 agonistát, inzulint és metionint tartalmazó gyógyászati készítmény
EP2359843A1 (de) 2010-01-21 2011-08-24 Sanofi Pharmazeutische Zusammensetzung zur Behandlung eines metabolischen Syndroms
TW201141513A (en) 2010-04-14 2011-12-01 Sanofi Aventis Insulin-siRNA conjugates
WO2012028172A1 (en) 2010-08-30 2012-03-08 Sanofi-Aventis Deutschland Gmbh Use of ave0010 for the manufacture of a medicament for the treatment of diabetes mellitus type 2
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
EP2548570A1 (de) 2011-07-19 2013-01-23 Sanofi Pharmazeutische Zusammensetzung zur Behandlung eines metabolischen Syndroms
AR087693A1 (es) 2011-08-29 2014-04-09 Sanofi Aventis Deutschland Combinacion farmaceutica para uso en el control glucemico en pacientes con diabetes de tipo 2
AR087744A1 (es) 2011-09-01 2014-04-16 Sanofi Aventis Deutschland Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa
US20130231281A1 (en) 2011-11-02 2013-09-05 Adocia Rapid acting insulin formulation comprising an oligosaccharide
CN107952065A (zh) 2012-11-13 2018-04-24 阿道恰公司 包含经取代阴离子化合物的速效胰岛素制剂
FR3020947B1 (fr) 2014-05-14 2018-08-31 Adocia Composition aqueuse comprenant au moins une proteine et un agent solubilisant, sa preparation et ses utilisations
US9795678B2 (en) 2014-05-14 2017-10-24 Adocia Fast-acting insulin composition comprising a substituted anionic compound and a polyanionic compound
US9656017B2 (en) 2014-06-20 2017-05-23 Howard E. Greene Infusion delivery devices and methods
HRP20230470T1 (hr) 2014-12-12 2023-07-21 Sanofi-Aventis Deutschland Gmbh Formulacija fiksnog omjera inzulin glargin/liksisenatid
AR102869A1 (es) 2014-12-16 2017-03-29 Lilly Co Eli Composiciones de insulina de rápida acción
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患之治療
JO3749B1 (ar) 2015-08-27 2021-01-31 Lilly Co Eli تركيبات إنسولين سريعة المفعول
FR3043557B1 (fr) 2015-11-16 2019-05-31 Adocia Composition a action rapide d'insuline comprenant un citrate substitue
CR20190522A (es) 2017-06-01 2020-01-15 Lilly Co Eli Composiciones de insulina de rápida acción
EP3915571A1 (de) * 2020-05-29 2021-12-01 Adocia Pharmazeutische zusammensetzung in form einer injizierbaren wässrigen lösung mit mindestens einem schnell wirkenden insulinanalogon und einem glucagon-suppressor mit prandialer wirkung
EP3915572A1 (de) * 2020-05-29 2021-12-01 Adocia Pharmazeutische zusammensetzung in form einer injizierbaren wässrigen lösung mit mindestens einem schnell wirkenden insulinanalogon und einem glucagon-suppressor mit prandialer wirkung

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3364116A (en) * 1964-11-02 1968-01-16 Squibb & Sons Inc Method of use of desalanino insulin compositions
US3758683A (en) * 1971-04-30 1973-09-11 R Jackson Insulin product
DE2252157C3 (de) * 1972-10-25 1976-03-18 Hoechst Ag Zwischenprodukte zur herstellung von insulin, insulin-analogen und -derivaten und verfahren zur herstellung von insulin, insulin analogen und derivaten
NL7314766A (de) * 1972-10-31 1974-05-02
DE2253327A1 (de) * 1972-10-31 1974-05-09 Hoechst Ag Verfahren zur herstellung von insulin, insulin-analogen und -derivaten
DK147437A (en) * 1980-02-11 1900-01-01 Process for preparing human insulin or threonine B30 esters of human insulin, or a salt or complex thereof
AU550068B2 (en) * 1981-03-10 1986-02-27 Novo Nordisk A/S Zinc insulin stabilized with calcium or magnesium salts
CA1176158A (en) * 1981-08-27 1984-10-16 Ronald E. Chance Pharmaceutical formulations comprising human insulin and human c-peptide
DE3209184A1 (de) * 1982-03-13 1983-09-15 Hoechst Ag, 6230 Frankfurt Verfahren zur umwandlung von praeproinsulinanaloga zu insulinen
DE3326473A1 (de) * 1983-07-22 1985-01-31 Hoechst Ag, 6230 Frankfurt Pharmazeutisches mittel zur behandlung des diabetes mellitus
DK347086D0 (da) * 1986-07-21 1986-07-21 Novo Industri As Novel peptides
DK119785D0 (da) * 1985-03-15 1985-03-15 Nordisk Gentofte Insulinpraeparat
PH25772A (en) * 1985-08-30 1991-10-18 Novo Industri As Insulin analogues, process for their preparation

Also Published As

Publication number Publication date
EP0280534A3 (en) 1990-01-31
IE62879B1 (en) 1995-03-08
JP2606915B2 (ja) 1997-05-07
FI884914A0 (fi) 1988-10-24
WO1988006599A1 (en) 1988-09-07
AU612141B2 (en) 1991-07-04
PT86819A (pt) 1988-03-01
JPH01502434A (ja) 1989-08-24
DE3880346D1 (de) 1993-05-27
DE3880346T2 (de) 1993-07-29
NZ223630A (en) 1989-11-28
NL300029I1 (nl) 2001-02-01
CA1339416C (en) 1997-09-02
IE880499L (en) 1988-08-25
PT86819B (pt) 1992-05-29
EP0280534A2 (de) 1988-08-31
FI884914L (fi) 1988-10-24
AU1397688A (en) 1988-09-26
EP0280534B1 (de) 1993-04-21
ES2053723T3 (es) 1994-08-01

Similar Documents

Publication Publication Date Title
DE10075034I1 (de) Insulinderivate
TR26815A (tr) Azolilmetil-sikropil türevleri
BG90716A (bg) Спринцовка
PT88672A (pt) Syringe
BR8901828A (pt) Seringa
DK620388D0 (da) Cycliske derivater
BR8903902A (pt) Seringa
TR24894A (tr) N-FENILPIRAZOL TüREVLERI
DK507188A (da) Cholecalciferolderivater
DK378088A (da) Alkenderivater
DK49688D0 (da) Propiolophenonderivater
DK271088A (da) Tienopyridinderivater
DK327488D0 (da) Kanyle
DK275490D0 (da) Kanyle
DK495188A (da) Ekspressionsvektor
DK695788D0 (da) Naphtalenderivater
DK71488D0 (da) Dipenylethylen-derivater
DK733688D0 (da) Dioxazocinderivater
DK313789D0 (da) Thiadiazinonderivater
ATE88353T1 (de) Insulinderivate.
DK474488D0 (da) Isoxazol-beta-carbolinderivater
DK666089A (da) Sproejte
KR880021395U (ko) 세척기
SE8702294D0 (sv) Injektionsspruta
SE8704688D0 (sv) Injektionsspruta

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8310 Action for declaration of annulment
8313 Request for invalidation rejected/withdrawn
8325 Change of the main classification

Ipc: C07K 14/62